Malte Peters, M.D. joined MorphoSys AG in 2017 as Chief Development Officer and a member of the management board and was appointed Chief Research and Development Officer in March 2020. Previously, he worked at Sandoz International, Holzkirchen, Germany, where he was Global Head of Clinical Development of the Biopharmaceuticals Business Unit. Prior to this position, he served as Clinical Head and Site Head for Basel and East Hanover in Oncology Translational Medicine at Novartis. Malte held teaching appointments in Internal Medicine and Biochemistry at the University of Mainz, Germany.
Malte received his MD degree from the Freie Universität Berlin, Germany, and was trained at the Universities of Padova, Italy and Bochum and Berlin, Germany. He received his habilitation in Internal Medicine from the University of Mainz, Germany. Subsequently, he served as Research Scientist at the Amgen Research Institute in Toronto, Canada, as Director of Cancer Research at Merck KgaA in Darmstadt, Germany and as Medical Director at Micromet AG in Munich, Germany.